Wells Fargo
AARD

Wells Fargo’s Aardvark Therapeutics AARD Stock Holding History

Wells Fargo’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7K Sell
4,707
-9,373
-67% -$97.2K ﹤0.01% 5822
2025
Q4 		$185K Buy
14,080
+10,163
+259% +$127K ﹤0.01% 5109
2025
Q3 		$52.1K Buy
3,917
+678
+21% +$7.65K ﹤0.01% 5539
2025
Q2 		$43.8K Buy
+3,239
New +$33.4K ﹤0.01% 5556

Other funds holding AARD

DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Wells Fargo's AARD Position: Q1 2026 in Review

Wells Fargo reduced its Aardvark Therapeutics (AARD) stake by 67% in Q1 2026, selling an estimated $97.2K and leaving 4,707 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #5822.

Wells Fargo first reported a position in AARD in Q2 2025 and has held it in 4 quarters since. The position peaked at $185K in Q4 2025. 79 funds tracked by Wall St. Rank hold AARD as of Q1 2026.

  • Wells Fargo held 4,707 shares of Aardvark Therapeutics worth $17.7K as of Q1 2026.
  • Wells Fargo sold 9,373 Aardvark Therapeutics shares in Q1 2026, an estimated $97.2K.
  • Aardvark Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5822 holding.
  • Wells Fargo first reported a position in Aardvark Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Wells Fargo's Aardvark Therapeutics position peaked at $185K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.